Asparaginase erwinia chrysanthemi Pregnancy and Breastfeeding Warnings
Asparaginase erwinia chrysanthemi is also known as: Erwinaze
Asparaginase erwinia chrysanthemi Pregnancy Warnings
Asparaginase Erwinia chrysanthemi has been assigned to pregnancy category C by the FDA. Animal studies have not been conducted with asparaginase Erwinia chrysanthemi. There are no adequate and well controlled studies of asparaginase Erwinia chrysanthemi in pregnant women. Asparaginase Erwinia chrysanthemi is only recommended for use during pregnancy when the potential benefit outweighs the risk to the developing fetus.
Asparaginase erwinia chrysanthemi Breastfeeding Warnings
There are no data on the excretion of asparaginase Erwinia chrysanthemi into human milk. Since many drugs are excreted in human milk, and because of the potential for serious adverse reactions in nursing infants from asparaginase Erwinia chrysanthemi, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
- asparaginase Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.